|
gptkbp:instanceOf
|
gptkb:disease
|
|
gptkbp:abbreviation
|
gptkb:MS
|
|
gptkbp:affects
|
central nervous system
|
|
gptkbp:alsoKnownAs
|
gptkb:Multiple_Sclerosis
|
|
gptkbp:associatedWith
|
gptkb:depression
gptkb:Lhermitte's_sign
spasticity
bladder dysfunction
oligoclonal bands in CSF
optic neuritis
Uhthoff's phenomenon
heat sensitivity
lesions in brain and spinal cord
|
|
gptkbp:cause
|
disability
autoimmune response
|
|
gptkbp:characterizedBy
|
demyelination
neurodegeneration
|
|
gptkbp:commonIn
|
gptkb:women
|
|
gptkbp:diagnosedBy
|
MRI
evoked potentials
lumbar puncture
|
|
gptkbp:field
|
neurology
|
|
gptkbp:firstDescribed
|
gptkb:Jean-Martin_Charcot
1868
|
|
gptkbp:hasNoCure
|
true
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Sclerosis, Multiple
|
|
gptkbp:ICD-10_code
|
G35
|
|
gptkbp:MeSH_ID
|
D009103
|
|
gptkbp:OMIM
|
126200
|
|
gptkbp:onset
|
young adults
|
|
gptkbp:prevalence
|
2.8 million people worldwide
|
|
gptkbp:riskFactor
|
gptkb:Epstein-Barr_virus_infection
smoking
genetic predisposition
vitamin D deficiency
|
|
gptkbp:symptom
|
fatigue
muscle weakness
cognitive impairment
difficulty with coordination
numbness
vision problems
|
|
gptkbp:treatment
|
disease-modifying therapies
physical therapy
corticosteroids
immunomodulatory drugs
|
|
gptkbp:type
|
gptkb:primary_progressive_MS
gptkb:progressive-relapsing_MS
gptkb:relapsing-remitting_MS
gptkb:secondary_progressive_MS
|
|
gptkbp:bfsParent
|
gptkb:D009290
|
|
gptkbp:bfsLayer
|
8
|